GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 133.79 USD -1.69% Market Closed
Market Cap: 3.9B USD

Wall Street
Price Targets

WGS Price Targets Summary
GeneDx Holdings Corp

Wall Street analysts forecast WGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WGS is 167.51 USD with a low forecast of 141.4 USD and a high forecast of 194.25 USD.

Lowest
Price Target
141.4 USD
6% Upside
Average
Price Target
167.51 USD
25% Upside
Highest
Price Target
194.25 USD
45% Upside
GeneDx Holdings Corp Competitors:
Price Targets
DNTL
dentalcorp Holdings Ltd
4% Upside
METROPOLIS
Metropolis Healthcare Ltd
18% Upside
INNV
InnovAge Holding Corp
29% Upside
ADUS
Addus Homecare Corp
30% Upside
6197
Solasto Corp
35% Downside
INFU
InfuSystem Holdings Inc
62% Upside
FLGT
Fulgent Genetics Inc
29% Upside
V3V
Vita 34 AG
25% Upside

Revenue
Forecast

Revenue Estimate
GeneDx Holdings Corp

For the last 5 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 9%. The projected CAGR for the next 4 years is 26%.

9%
Past Growth
26%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
67%
Average Beat

Net Income
Forecast

Net Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WGS's stock price target?
Price Target
167.51 USD

According to Wall Street analysts, the average 1-year price target for WGS is 167.51 USD with a low forecast of 141.4 USD and a high forecast of 194.25 USD.

What is GeneDx Holdings Corp's Revenue forecast?
Projected CAGR
26%

For the last 5 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 9%. The projected CAGR for the next 4 years is 26%.

Back to Top